Become A Featured Company

RavenQuest Reports Progress Across All ‘Four Pillars’

Ryan Allway

May 30th, 2018

Exclusive, News, Top News

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis later this year. While there are many companies active in the space, there are few that are as unique and diversified as RavenQuest BioMed Inc. (CSE: RQB) (OTCQB: RVVQF), which has taken a ‘four pillar’ approach to the cannabis industry to build long-term shareholder value.

RavenQuest BioMed recently released a corporate update reporting progress across all four of its pillars, including investments, indigenous peoples outreach, consulting services, and research and development. Investors may want to take note of these developments and the company’s many near-term catalysts coming up just as adult-use cannabis becomes legal.

Ramping Up Operations

RavenQuest BioMed invested in two new projects at the memorandum of understanding phase, including a 250,000 sq. ft. joint venture with Fort McMurray #468 First Nation and the acquisition of Western AgriPharma Limited, a late-stage ACMPR applicant with 125,000 sq. ft. of growing space. Management anticipates that these two investments will increase its production footprint from 11,000 kilograms to over 50,000 kilograms of dried cannabis per year.

At the same time, the company’s licensed (cultivation) Bloomera facility in Toronto completed the first of two harvests required by Health Canada for license to sell and dispense. The facility successfully passed all chemistry and microbiological testing on the first grow cycle and management expects a license to sell and dispense by July. Additionally, the company’s Alberta Green Biotech facility is fully funded and expected to be licensed to cultivate by July.

The company also recently signed a new lease in downtown Edmonton where it plans to open its flagship retail recreational cannabis store. The space is strategically located within Edmonton’s downtown nightlife, concert halls, conference center, public transport, and popular “ICE District” that’s home to NHL hockey and a densely populated residential area.

Research & Partnerships

RavenQuest BioMed’s Head of Government and Indigenous Relations, Bill Robinson, recently hosted the first national conference call for the Indigenous Peoples’ Cannabis Association (IPCA). Over the past several months, IPCA’s membership has continued to rapidly grow along with interest from indigenous communities looking to participate in the cannabis industry. These relationships could be extremely valuable to the company over the long run.

CEO George Robinson will also be working to expand the company’s presence by speaking at several upcoming cannabis industry events, including:

  • Arcview International Investor Forum: April 30-May 2 Vancouver, BC
  • Institutional Capital & Cannabis Conference: May 21-22 Los Angeles, CA
  • International Cannabis Business Conference: June 24-25 Vancouver, BC
  • The Money Show (Cannabis Investing Symposium): August 23-25, San Francisco, CA
  • The Money Show (Cannabis Investing Symposium): Sept 14-15, Toronto, ON
  • Institute of Public Administration of Canada (Pracademic policy workshop): Aug. 22, Quebec City, PQ

In addition to building strategic relationships, the company received a $480,000 grant from the Natural Sciences & Engineering Research Council (NSERC) along with its research partner, McGill University. These funds will be combined with the company’s cash and in-kind contributions to yield a total of $1.2 million over three years. These funds will be aimed at recognition, stabilization, and yield maximization of the cannabis plant.

Looking Ahead

RavenQuest BioMed Inc. (CSE: RQB) (OTCQB: RVVQF) has made tremendous progress in advancing its four pillars approach to the cannabis industry. The investment division has continued to expand its portfolio; the indigenous peoples outreach has seen strong early traction; the services division produced over $600,000 in revenue last quarter; and, the R&D branch successfully secured a NSERC grant to improve cannabis production.

For more information, visit the company’s website or download their investor presentation.

Disclaimer  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading